HCC
These results suggest that IFN-alpha gene therapy is a promising strategy to treat HCC patients who have concomitant liver cirrhosis.
These results suggest that <span class="gene" id="18665156-8-27-36">IFN-alpha</span> gene therapy is a promising strategy to treat <span class="disease" id="18665156-8-83-86">HCC</span> patients who have concomitant liver cirrhosis.